Canaccord Genuity Group started coverage on shares of Waldencast (NASDAQ:WALD – Free Report) in a research note published on Friday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $5.00 price objective on the stock.
Other equities research analysts have also recently issued reports about the stock. DA Davidson lifted their price objective on shares of Waldencast from $6.50 to $7.25 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $6.00 price objective on shares of Waldencast in a report on Wednesday, October 9th.
Get Our Latest Stock Report on Waldencast
Waldencast Trading Up 3.3 %
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. Marshall Wace LLP acquired a new position in Waldencast during the second quarter worth approximately $37,000. Bleakley Financial Group LLC increased its position in Waldencast by 75.2% during the third quarter. Bleakley Financial Group LLC now owns 26,297 shares of the company’s stock worth $96,000 after buying an additional 11,288 shares during the period. Catalina Capital Group LLC acquired a new position in Waldencast during the first quarter worth approximately $73,000. Norden Group LLC acquired a new position in Waldencast during the first quarter worth approximately $92,000. Finally, McAdam LLC acquired a new position in Waldencast during the third quarter worth approximately $62,000. Institutional investors and hedge funds own 41.97% of the company’s stock.
About Waldencast
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Featured Articles
- Five stocks we like better than Waldencast
- Retail Stocks Investing, Explained
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How Can Investors Benefit From After-Hours Trading
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.